Efficacy of EPD-09-25 for Eyelid Hygiene Before and After Eye Surgery.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorVISUfarma SpA

About this trial

This is an interventional, open-label, two-arms clinical trial, randomized 1:1 (EPD treatment or no eyelid hygiene treatment) in patients scheduled for eye surgery (cataract surgery). The purpose of the study is to evaluate the importance of the cleansing action of EPD-09-25 before and after eye surgery.

Eligibility criteria

Qualifiers

Male and female adults aged ≥ 18 and ≤ 85 years.

Clinical diagnosis of cataract scheduled for cataract surgery.

Provision of written informed consent as approved by the Ethics Committee (EC).

Disqualifiers

TBUT < 10s

SPEED score > 4

Recent (≤8 weeks) use or dose adjustment of systemic medications known to affect tear film or lacrimal section systemic antihistamines, antidepressant such as SSRI/SNRI/TCA, antiparkinsonian agents, anticholinergics, oral isotretinoin.

Active or uncontrolled ocular allergy (e.g. allergic conjunctivitis, keratoconjunctivitis) within 4 weeks prior to screening or requiring therapy during the study.

Trial design

Treatments tested in this trial

  • EPD Eyelid wipes

Treatment groups

100 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators